Coherus Oncology (CHRS) Financials: Revenue & Earnings
CHRS$1.15+0.08 +7.48%
$177.68M
Market Cap
-1.05
P/E
3.89
Forward P/E
—
Score
Coherus Oncology (CHRS) Financials: Revenue & Earnings
CHRS price $1.15 +0.08 +7.48%
- Ticker
- CHRS
- Price
- $1.15
- Change
- +0.08 +7.48%
- Market cap ?
- $177.68M
- P/E ?
- -1.05
- Forward P/E ?
- 3.89
- Dividend yield ?
- 0.00%
- Beta ?
- 0.99
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 190106000 | 1556000 | 1556000 | 356071000 | 475824000 | 326551000 | 211042000 | 257244000 | 266960000 | 42172000 |
Coherus Oncology, Inc. is a biopharmaceutical company primarily focused on the research, development, and commercialization of cancer immunotherapies across the United States. The company's commercialized products include several biosimilar therapies. These comprise UDENYCA, a long-acting granulocyte-colony stimulating factor biosimilar to Neulasta; YUSIMRY, an equivalent to Humira, prescribed for inflammatory…
Fair value
CHRS fair value $6.48. Price $1.15. Price is 82% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 13.02M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.73% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 154.50M. Net debt -48.54M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.21 | — | 15.98M |
| 2026-08-05 | -0.19 | -0.25 | 14.31M | 14.41M |
| 2026-05-11 | -0.25 | -0.26 | 12.31M | 14.22M |
| 2026-03-09 | -0.34 | -0.36 | 12.75M | 13.91M |
| 2025-11-06 | -0.33 | -0.32 | 11.57M | 14.09M |
| 2025-08-07 | -0.34 | -0.31 | 10.25M | 11.99M |
| 2025-05-12 | -0.35 | -0.31 | 7.60M | 60.96M |
| 2025-03-10 | -0.44 | -0.10 | 54.14M | 44.15M |
| 2024-11-06 | -0.01 | -0.16 | 70.77M | 58.98M |
| 2024-08-08 | -0.14 | -0.21 | 64.98M | 61.37M |
| 2024-05-09 | -0.32 | -0.05 | 77.06M | 80.25M |
| 2024-03-13 | -0.62 | -0.21 | 91.52M | 96.40M |
| 2023-11-06 | -0.41 | -0.21 | 74.57M | 81.78M |
| 2023-08-02 | -0.38 | -0.52 | 58.72M | 82.24M |
| 2023-05-08 | -0.75 | -0.61 | 32.44M | 47.44M |
| 2023-03-06 | -0.60 | -0.64 | 45.35M | 47.69M |
| 2022-11-08 | -0.96 | -0.53 | 45.42M | 56.69M |
| 2022-08-04 | -0.65 | -0.96 | 60.15M | 62.04M |
| 2022-05-05 | -1.24 | -0.80 | 60.12M | 69.54M |
| 2022-02-17 | -0.60 | -0.61 | 73.37M | 82.61M |
| 2021-11-08 | -0.49 | -0.40 | 82.50M | 61.88M |
| 2021-08-05 | -0.40 | -0.25 | 87.64M | 88.18M |
| 2021-05-06 | -2.37 | 0.09 | 83.03M | 99.57M |
| 2021-02-24 | 0.12 | 0.23 | 110.42M | 115.12M |
| 2020-11-05 | 0.33 | 0.41 | 113.55M | 135.71M |
| 2020-08-06 | 0.70 | 0.33 | 135.67M | 100.00M |
| 2020-05-07 | 0.54 | 0.56 | 116.18M | 135.54M |
| 2020-02-27 | 0.56 | 0.72 | 123.86M | 161.46M |
| 2019-11-06 | 0.63 | 0.51 | 111.68M | 90.41M |
| 2019-08-01 | 0.32 | -0.08 | 83.43M | — |
| 2019-05-09 | -0.29 | -0.46 | 37.10M | 60.12M |
| 2019-02-28 | -0.92 | -0.82 | — | — |
| 2018-11-08 | -0.87 | -0.79 | — | — |
| 2018-08-08 | -0.68 | -0.70 | — | — |
| 2018-05-10 | -0.74 | -0.77 | — | — |
| 2018-03-08 | -0.84 | -0.81 | — | 1.50M |
| 2017-11-06 | -1.09 | -1.05 | — | 1.16M |
| 2017-08-07 | -1.08 | -1.29 | 1.40M | 1.55M |
| 2017-05-08 | -1.54 | -1.54 | 161.00K | 143.23K |
| 2017-03-13 | -1.71 | -1.63 | 844.00K | 542.92K |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Satvat Ali J. | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Satvat Ali J. | Buy | 30.00K | — | — |
| 2026-06-05 | Karachun Rita A | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Karachun Rita A | Buy | 30.00K | — | — |
| 2026-06-05 | Newcomer Lee Nisley | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Newcomer Lee Nisley | Buy | 30.00K | — | — |
| 2026-06-05 | Ryan Michael Lee | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Ryan Michael Lee | Buy | 30.00K | — | — |
| 2026-06-05 | O'Donnell-Tormey Jill | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | O'Donnell-Tormey Jill | Buy | 30.00K | — | — |
| 2026-06-05 | Wahlstrom Mats | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Wahlstrom Mats | Buy | 30.00K | — | — |
| 2026-06-05 | Newton Charles W. | Buy | 60.00K | $1.45 | 87.00K |
| 2026-06-05 | Newton Charles W. | Buy | 30.00K | — | — |
| 2026-05-29 | McMichael Bryan J | Buy | 100.00K | $1.59 | 159.00K |
| 2026-05-29 | McMichael Bryan J | Buy | 30.00K | $1.59 | 47.70K |
| 2026-05-29 | McMichael Bryan J | Buy | 25.00K | $1.59 | 39.75K |
| 2026-05-29 | McMichael Bryan J | Buy | 15.00K | $1.59 | 23.85K |
| 2026-05-29 | McMichael Bryan J | Sell | 25.00K | $6.00 | 150.00K |
| 2026-05-29 | McMichael Bryan J | Sell | 30.00K | $5.44 | 163.20K |
| 2026-05-29 | McMichael Bryan J | Sell | 100.00K | $14.76 | 1.48M |
| 2026-05-29 | McMichael Bryan J | Sell | 25.00K | $14.67 | 366.75K |
| 2026-05-29 | McMichael Bryan J | Sell | 15.00K | $10.78 | 161.70K |
| 2026-05-29 | McMichael Bryan J | Sell | 25.00K | $9.87 | 246.75K |
| 2026-05-29 | Lanfear Dennis M | Buy | 500.00K | $1.59 | 795.00K |
| 2026-05-29 | Lanfear Dennis M | Buy | 450.00K | $1.59 | 715.50K |
| 2026-05-29 | Lanfear Dennis M | Buy | 402.50K | $1.59 | 639.98K |
| 2026-05-29 | Lanfear Dennis M | Buy | 400.00K | $1.59 | 636.00K |
| 2026-05-29 | Lanfear Dennis M | Buy | 225.00K | $1.59 | 357.75K |
| 2026-05-29 | Lanfear Dennis M | Buy | 200.00K | $1.59 | 318.00K |
| 2026-05-29 | Lanfear Dennis M | Buy | 125.00K | $1.59 | 198.75K |
| 2026-05-29 | Lanfear Dennis M | Sell | 402.50K | $10.37 | 4.17M |
| 2026-05-29 | Lanfear Dennis M | Sell | 225.00K | $5.44 | 1.22M |
| 2026-05-29 | Lanfear Dennis M | Sell | 500.00K | $18.33 | 9.16M |
| 2026-05-29 | Lanfear Dennis M | Sell | 500.00K | $17.73 | 8.87M |
| 2026-05-29 | Lanfear Dennis M | Sell | 450.00K | $12.37 | 5.57M |
| 2026-05-29 | Lanfear Dennis M | Sell | 400.00K | $10.05 | 4.02M |
| 2026-05-29 | Lanfear Dennis M | Sell | 125.00K | $17.60 | 2.20M |
| 2026-05-29 | Lanfear Dennis M | Sell | 200.00K | $12.70 | 2.54M |
| 2026-05-29 | Lanfear Dennis M | Sell | 402.50K | $15.94 | 6.42M |
| 2026-01-23 | Lanfear Dennis M | Buy | 375.00K | — | — |
| 2026-01-23 | Lanfear Dennis M | Buy | 750.00K | $2.06 | 1.54M |
| 2026-01-22 | McMichael Bryan J | Buy | 225.00K | $1.59 | 357.75K |
| 2026-01-22 | McMichael Bryan J | Buy | 112.50K | — | — |
| 2026-01-20 | McMichael Bryan J | Sell | 1.72K | $1.55 | 2.66K |
| 2026-01-20 | Lanfear Dennis M | Sell | 11.84K | $1.55 | 18.35K |
| 2025-06-12 | O'Donnell-Tormey Jill | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Newcomer Lee Nisley | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Wahlstrom Mats | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Ryan Michael Lee | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Karachun Rita A | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Erbez Georgia | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Newton Charles W. | Buy | 112.00K | $0.79 | 88.52K |
| 2025-06-12 | Satvat Ali J. | Buy | 112.00K | $0.79 | 88.52K |
| 2025-05-23 | Wahlstrom Mats | Sell | 99.99K | $0.74 | 73.88K |
| 2025-05-07 | McMichael Bryan J | Buy | 200.00K | $0.95 | 189.24K |
| 2025-05-07 | Lanfear Dennis M | Buy | 375.00K | $0.95 | 354.82K |
| 2025-01-20 | McMichael Bryan J | Sell | 1.71K | $1.39 | 2.38K |
| 2025-01-20 | Reider Paul | Sell | 4.86K | $1.39 | 6.75K |
| 2025-01-20 | Lanfear Dennis M | Sell | 11.81K | $1.39 | 16.42K |
| 2025-01-10 | Lanfear Dennis M | Buy | 575.00K | $1.47 | 845.25K |
| 2025-01-07 | McMichael Bryan J | Sell | 1.71K | $1.57 | 2.69K |
| 2025-01-04 | Lanfear Dennis M | Sell | 11.81K | $1.66 | 19.60K |
| 2025-01-04 | Reider Paul | Sell | 2.28K | $1.66 | 3.78K |
| 2025-01-03 | McMichael Bryan J | Buy | 160.00K | $1.66 | 265.60K |
| 2025-01-03 | Reider Paul | Buy | 160.00K | $1.66 | 265.60K |
| 2024-12-13 | Reider Paul | Sell | 2.07K | $1.61 | 3.34K |
| 2024-08-07 | McMichael Bryan J | Buy | 75.00K | $1.24 | 93.00K |
| 2024-07-22 | Lanfear Dennis M | Buy | 196.50K | $2.41 | 473.56K |
| 2024-07-22 | Reider Paul | Buy | 40.00K | $2.41 | 96.40K |
| 2024-06-04 | Karachun Rita A | Buy | 168.00K | $1.78 | 299.04K |
| 2024-06-04 | Erbez Georgia | Buy | 114.00K | $1.78 | 202.92K |
| 2024-06-03 | Newton Charles W. | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | Ryan Michael Lee | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | Wahlstrom Mats | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | STOLPER MARK | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | Newcomer Lee Nisley | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | TZOUMAKAS KIMBERLY JO | Buy | 112.00K | $1.76 | 197.12K |
| 2024-06-03 | O'Donnell-Tormey Jill | Buy | 112.00K | $1.76 | 197.12K |
| 2024-05-31 | Karachun Rita A | Other | 0 | — | — |
| 2024-02-20 | Erbez Georgia | Buy | 54.00K | $2.59 | 139.86K |
| 2024-02-20 | Erbez Georgia | Other | 0 | — | — |
| 2024-02-09 | Wahlstrom Mats | Buy | 99.99K | — | — |
| 2024-02-09 | Wahlstrom Mats | Sell | 99.99K | — | — |
| 2024-02-01 | Wahlstrom Mats | Buy | 44.99K | $1.67 | 75.00K |
| 2024-02-01 | Wahlstrom Mats | Buy | 15.00K | $1.67 | 25.00K |
| 2024-02-01 | Wahlstrom Mats | Sell | 44.99K | $1.67 | 75.00K |
| 2024-01-20 | Lanfear Dennis M | Sell | 11.22K | $2.44 | 27.37K |
| 2024-01-20 | Reider Paul | Sell | 4.85K | $2.44 | 11.84K |
| 2024-01-20 | McMichael Bryan J | Sell | 1.71K | $2.44 | 4.17K |
| 2024-01-07 | McMichael Bryan J | Sell | 1.71K | $2.87 | 4.90K |
| 2024-01-05 | Lanfear Dennis M | Buy | 575.00K | $3.14 | 1.81M |
| 2024-01-04 | Lanfear Dennis M | Sell | 11.78K | $2.92 | 34.40K |
| 2024-01-04 | Reider Paul | Sell | 2.27K | $2.92 | 6.64K |
| 2024-01-02 | McMichael Bryan J | Buy | 125.00K | $3.14 | 392.50K |
| 2024-01-02 | Reider Paul | Buy | 160.00K | $3.14 | 502.40K |
| 2023-12-31 | Stilwell McDavid | Sell | 18.44K | $3.33 | 61.41K |
| 2023-12-13 | Reider Paul | Sell | 2.05K | $2.37 | 4.86K |
| 2023-11-22 | Lanfear Dennis M | Buy | 258.94K | $1.42 | 366.92K |
| 2023-11-22 | Lanfear Dennis M | Sell | 223.10K | $2.02 | 449.77K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 152, holders -10 vs prior quarter. Ownership 46.23%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| TIMOTHY G. YOUNGQUIST 2020 IRREVOCABLE TRUST | 13.05M | 759.82K | +6.18% | 18.27M |
| BLACKROCK, INC. | 12.00M | 1.64M | +15.81% | 16.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.95M | 496.73K | +9.11% | 8.33M |
| GEODE CAPITAL MANAGEMENT, LLC | 3.69M | 563.99K | +18.07% | 5.16M |
| SAMSARA BIOCAPITAL, LLC | 3.43M | 0 | 0.00% | 4.80M |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 3.04M | 0 | 0.00% | 4.18M |
| STATE STREET CORP | 2.38M | 56.45K | +2.43% | 3.34M |
| TWO SIGMA INVESTMENTS, LP | 2.26M | -42.59K | -1.85% | 3.16M |
| CM MANAGEMENT, LLC | 2.10M | 0 | 0.00% | 2.94M |
| C WORLDWIDE GROUP HOLDING A/S | 1.93M | 0 | 0.00% | 2.70M |
| ALYESKA INVESTMENT GROUP, L.P. | 1.73M | -516.77K | -22.97% | 2.43M |
| HUDSON BAY CAPITAL MANAGEMENT LP | 1.69M | -11.98K | -0.70% | 2.37M |
| AQR CAPITAL MANAGEMENT LLC | 1.33M | 124.16K | +10.29% | 1.86M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.23M | 1.23M | New | 1.72M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.23M | 72.17K | +6.24% | 1.72M |
| PANAGORA ASSET MANAGEMENT INC | 1.14M | -321.99K | -22.06% | 1.59M |
| NORTHERN TRUST CORP | 1.13M | 215.67K | +23.60% | 1.58M |
| VANGUARD FIDUCIARY TRUST CO | 1.02M | 66.07K | +6.96% | 1.42M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 900.00K | 0 | 0.00% | 1.26M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 883.45K | 278.93K | +46.14% | 1.24M |
| UBS GROUP AG | 760.36K | 213.15K | +38.95% | 1.06M |
| GOLDMAN SACHS GROUP INC | 602.08K | -94.08K | -13.51% | 842.90K |
| RENAISSANCE TECHNOLOGIES LLC | 563.06K | 231.36K | +69.75% | 788.28K |
| STRS OHIO | 395.60K | 71.60K | +22.10% | 553.84K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 391.00K | -50.00K | -11.34% | 547.40K |
Earnings and financials
Coherus Oncology, Inc. (CHRS) trades at $1.15, with a market cap of $177.68M and a trailing P/E of -1.05. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 190106000 | 1556000 | 1556000 | 356071000 | 475824000 | 326551000 | 211042000 | 257244000 | 266960000 | 42172000 |
Insights · Dividends · Forecast · Financials · Learn